CN102119967A - Medicament for preventing respiratory infectious disease - Google Patents
Medicament for preventing respiratory infectious disease Download PDFInfo
- Publication number
- CN102119967A CN102119967A CN 201010620278 CN201010620278A CN102119967A CN 102119967 A CN102119967 A CN 102119967A CN 201010620278 CN201010620278 CN 201010620278 CN 201010620278 A CN201010620278 A CN 201010620278A CN 102119967 A CN102119967 A CN 102119967A
- Authority
- CN
- China
- Prior art keywords
- radix
- infectious disease
- respiratory infectious
- medicine
- parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a medicament for preventing respiratory infectious disease, which is mainly prepared from the Chinese herbal medicines such as honeysuckle, forsythia, isatis root, rhizome of cyrtomium and the like, and has the characteristics of good preventive effect, small side effect and the like.
Description
(1) technical field
The present invention relates to a kind of medicine that prevents respiratory infectious disease.
(2) background technology
Mainly by air borne, it comprises the source of infection, route of transmission, three basic links of Susceptible population to respiratory infectious disease.
The source of infection: along with development, climate change, life change, the chemical drugs of society are on the increase, under these factors, virus and antibacterial also constantly change, the infectious disease of the not clear cause of disease, be difficult to find the source of infection at short notice, make troubles just for present medical science.
Route of transmission: air borne, water source propagation, dietetic spread, sexual intercourse propagation and contact transmission.Airborne respiratory tract disease is to be difficult to control, because have a large population, social wide, population density is big, also is a great problem of respiratory infectious disease.
Susceptible population: majority's susceptible, not susceptible of a few peoples is arranged, prove that the antibody of self can be resisted virus in the human body.
The prophylactic agent of respiratory infectious disease is a lot of at present, but most of effect is all undesirable, is necessary prior art is improved.
(3) summary of the invention
The object of the present invention is to provide a kind of improve body immunity, safe and practical, and can effectively reduce the Chinese medicine composition medicine of human respiratory tract's infectious disease sense sickness rate.
The present invention is directed to the pathogenesis of respiratory infectious disease,, select drug component: Flos Lonicerae, Fructus Forsythiae, Radix Isatidis, Rhizoma Osmundae in conjunction with the modern Chinese medicine theory.
Flos Lonicerae: dispelling wind and heat pathogens, eliminating pathogenic heat from blood to cure dysentery can also cure cold.Modern study this product contains cyclohexanhexanol, flavonoid, inositol, Saponin, tannin etc.Can be antibacterial, resisiting influenza virus and dermatophytes, antiendotoxin, shock, minimizing intestinal be to cholesterol absorption.Also have infection, analgesic, promote effect such as leukocytes phagocytic.
Fructus Forsythiae: can removing toxicity for eliminating carbuncles eliminating stagnation, the title of " persons particularly liable to develop skin infection's panacea " is arranged.Pyretic toxicity is invaded the flesh table, and QI and blood is stopped poly-and the diseases such as obstructed, generation carbuncle sore tumefacting virus of stagnating, and can obtain good effect with this product.Its bitter in taste acting on the heart of distinguishing the flavor of, kind clearing away heart-fire, and having and the wind heat of loosing in clear can control fever and headache, xerostomia pharyngalgia that affection due to external wind and heat, heresy criminal are defended branch again, and pathogenic warmth is joined the army vexed uneasiness.Modern study, this product contain triterpenoid saponin, forsythol, sterol, alkaloid, oleanolic acid, Citrin and a small amount of volatilization wet goods.Have broad-spectrum antiseptic, infection, analgesic, heart tonifying, diuresis, blood pressure lowering, town effect such as to tell, protect the liver, Citrin can reduce vascular permeability and fragility, prevents oozing of blood.
Radix Isatidis: the effect of clearing away heat and cooling blood, resolving toxin and disinhibiting the throat is applicable to the pathogenic wind-warm seasonal noxious pathogen, fever and headache, laryngopharynx swelling and pain.Modern study, this product has inhibitory action to various pathogens, and leptospira is had killing action, and influenza virus, hepatitis B surface antigen are had obvious inhibitory action.And the reduction serum cholesterol arranged.
Rhizoma Osmundae: heat-clearing and toxic substances removing, cooling blood for hemostasis, parasite killing, prevention pestilence.
In order to reach better synergy, the present invention also can add: Folium Mori, Herba Menthae, Herba Schizonepetae, Radix Saposhnikoviae.
Folium Mori: dispelling wind and heat pathogens, liver heat removing and eyesight improving is controlled affection due to external wind and heat cough, and headache conjunctival congestion, and the disease such as have a dizzy spell of excessive rising of liver-YANG can be controlled dryness-heat impairing the lung, hemoptysis throat pain etc.
Herba Menthae: refresh oneself, throat, the wind heat of loosing, all diseases of tap holder order on the wind heat such as treatment headache, conjunctival congestion, toothache, laryngopharynx swelling and pain.
Herba Schizonepetae: relieving the exterior syndrome by diaphoresis, the ailment said due to cold or exposure of loosing, the refresh oneself, the rash poison, clear skin ulcer is swollen, controls headache that wind and cold causes, conjunctival congestion, laryngopharynx swelling and pain etc.
Radix Saposhnikoviae: control the title of the logical medicine of wind, the flesh table ailment said due to cold or exposure of loosing is removed meridians and is stayed effects such as wet, diaphoresis, the wind dehumidifying of loosing.
In order to reach further effect, medicine of the present invention also can further add: Radix Adenophorae (Radix Glehniae), Fructus Jujubae, Radix Glycyrrhizae.
Radix Adenophorae (Radix Glehniae): the effect of lung heat clearing inflammation, lung benefiting the moon, and energy detumescence and apocenosis, controlling has heat in the lung, and chest and diaphragm is had a pain, and coughs the lung abscess of vomiting bloody pus and the cough that the deficiency of the lung has heat.
Fructus Jujubae: the energy harmonizing drug, and the QI invigorating spleen reinforcing is arranged, the effect of nourishing blood to tranquillize the mind can be controlled weakness of the spleen and stomach, diseases such as anorexia and loose stool and blood deficiency hysteria.
Radix Glycyrrhizae: sweet gentle slow, with the same usefulness of fever and chills and warm and cool various kinds of drug in the side, can be in harmonious proportion the bias of various medicines, all medicines association can be played a role better.Can also nourish heart gas, relieving cough and moistening lung is dry.
Flos Lonicerae, Fructus Forsythiae, Radix Isatidis, Rhizoma Osmundae, function has heat-clearing and toxic substances removing, wind-dispelling heat-dissipating, the parasite killing dysentery relieving, infection, the fever and headache that energy eliminating carbuncle eliminating stagnation and multiple reason cause, laryngopharynx swelling and pain can prevent pestilence wind.
Respiratory infectious disease is at first invaded pulmonary and throat, fever and headache, and the cough hemoptysis, diseases such as laryngopharynx swelling and pain.Folium Mori and Herba Menthae can wind and heat dispersing, liver heat removing and eyesight improving, resolving toxin and disinhibiting the throat, treatment cough hemoptysis, laryngopharynx swelling and pain.Respiratory infectious disease, morbidity season is many, and spring, wind was the biography of all kinds of diseases and ailments based on ailment said due to cold or exposure in spring, summer, rain rainy season, morbidity is anxious, changes soon.The easiest yang-energy of hurting sb.'s feelings of damp being a kind of YIN pathogen is difficult to dispel in case invade internal organs, thus add Herba Schizonepetae, Radix Saposhnikoviae, the effect relieving the exterior syndrome by diaphoresis, the wind dehumidifying of loosing, virus is got rid of external with slight diaphoresis method.
The prevention respiratory infectious disease will strengthen human body antibody, improves body immunity, therefore adds Radix Adenophorae (Radix Glehniae), Fructus Jujubae, Radix Glycyrrhizae again, effect QI invigorating spleen reinforcing nourishing YIN and moistening the lung, on the row that coughs, subsides a swelling dense, tonifying the lung, spleen.
Drug component consumption of the present invention all has effect preferably in following ranges.
Drug component consumption of the present invention is: Flos Lonicerae 3-5 part, Fructus Forsythiae 2-4 part, Radix Isatidis 3-5 part, Rhizoma Osmundae 2-4 part.
Preferable amount is: Flos Lonicerae 3-4 part, Fructus Forsythiae 2.5-3.5 part, Radix Isatidis 3-4 part, Rhizoma Osmundae 2-3 part.
Drug component consumption of the present invention can also be: Flos Lonicerae 3-5 part, Fructus Forsythiae 2-4 part, Radix Isatidis 3-5 part, Rhizoma Osmundae 2-4 part, Folium Mori 3-5 part, Herba Menthae 2-4 part, Herba Schizonepetae 2-4 part, Radix Saposhnikoviae 2-4 part.
Preferable amount is: Flos Lonicerae 3-4 part, Fructus Forsythiae 2.5-3.5 part, Radix Isatidis 3-4 part, Rhizoma Osmundae 2-3 part, Folium Mori 3-4 part, Herba Menthae 2-3 part, Herba Schizonepetae 2-3 part, Radix Saposhnikoviae 2-3 part.
The further each component consumption of the present invention is: Flos Lonicerae 3-5 part, Fructus Forsythiae 2-4 part, Radix Isatidis 3-5 part, Rhizoma Osmundae 2-4 part, Folium Mori 3-5 part, Herba Menthae 2-4 part, Herba Schizonepetae 2-4 part, Radix Saposhnikoviae 2-4 part, Radix Adenophorae (Radix Glehniae) 2-4 part, Fructus Jujubae 2-4 part, Radix Glycyrrhizae 1-3 part.
Preferable amount is: Flos Lonicerae 3-4 part, Fructus Forsythiae 2.5-3.5 part, Radix Isatidis 3-4 part, Rhizoma Osmundae 2-3 part, Folium Mori 3-4 part, Herba Menthae 2-3 part, Herba Schizonepetae 2-3 part, Radix Saposhnikoviae 2-3 part, Radix Adenophorae (Radix Glehniae) 2-3 part, Fructus Jujubae 2-3 part, Radix Glycyrrhizae 1-2 part.
Medicine of the present invention is made decoction except the conventional method of Chinese medicine preparation, can also make various ways such as finished particle, capsule.
Characteristics such as the present invention is the summary that the inventor practises medicine for many years, and it is good to have preventive effect, and side effect is little.
In order to show that the present invention prevents the effect of respiratory infectious disease, the present invention is as follows through clinical observation:
The object of observation:
Prevention group: total number of persons 1000 people, male 550 people, women 450 people, 400 people that wherein are grown up, student 450 people, child 150 people.
Matched group: total number of persons 1000 people, male 560 people, women 440 people, 400 people that wherein are grown up, student 450 people, child 150 people.
In the test of respiratory infectious disease epidemic season, the prevention group is taken prophylactic agent of the present invention on request, and matched group is taken common Radix Isatidis granules.
Red, the antiadoncus of pharynx is arranged, stay one of nasal mucus, cough, heating etc. or several symptoms to be considered as ill.The result is as follows after 60 days:
The prevention group: number of the infected, male 7 people, women 13 people, 0 people that wherein is grown up, student 5 people, child 15 people, prevention effective percentage adult 100%, student's significant figure 98.7%, the child 90%.
Matched group: number of the infected 64 people that are grown up, student 95 people, child 37 people.
Prevention effective percentage adult 84%, the student 79%, and the child 75%.
The result shows that the effect of prevention respiratory infectious disease of the present invention is better than traditional prophylactic agent.Wherein child's sickness rate number is many, except the autoimmunity difference, may take medicine relevantly with the child is disagreeable, does not take medicine fully at regular time and quantity and does not cause drug effect to get deviation.
(4), the specific embodiment
Example 1 (main formula example)
3 parts of Flos Loniceraes, 4 parts of Fructus Forsythiaes, 3 parts of Radix Isatidis, 3 parts of Rhizoma Osmundae.
Example 2 (full side's upper limit example)
3 parts of Flos Loniceraes, 2 parts of Fructus Forsythiaes, 3 parts of Radix Isatidis, 2 parts of Rhizoma Osmundae, 3 parts on Folium Mori, 2 parts of Herba Menthaes, 2 parts of Herba Schizonepetae, 2 parts of Radix Saposhnikoviaes, 2 parts of Radix Adenophorae (Radix Glehniae), 2 parts in Fructus Jujubae, 1 part in Radix Glycyrrhizae.
Example 3 (full side's preference)
3.5 parts of Flos Loniceraes, 3.5 parts of Fructus Forsythiaes, 3.5 parts of Radix Isatidis, 2.5 parts of Rhizoma Osmundae, 3.5 parts on Folium Mori, 2.5 parts of Herba Menthaes, 2.5 parts of Herba Schizonepetae, 2.5 parts of Radix Saposhnikoviaes, 2.5 parts of Radix Adenophorae (Radix Glehniae), 2.5 parts in Fructus Jujubae, 2 parts in Radix Glycyrrhizae.
Claims (6)
1. medicine that prevents respiratory infectious disease, it is characterized in that: it mainly is made up of following bulk drugs: Flos Lonicerae 3-5 part, Fructus Forsythiae 2-4 part, Radix Isatidis 3-5 part, Rhizoma Osmundae 2-4 part.
2. the medicine of prevention respiratory infectious disease according to claim 1, its preferred weight part is: Flos Lonicerae 3-4 part, Fructus Forsythiae 2.5-3.5 part, Radix Isatidis 3-4 part, Rhizoma Osmundae 2-3 part.
3. the medicine of prevention respiratory infectious disease according to claim 1, its crude drug also has: Folium Mori 3-5 part, Herba Menthae 2-4 part, Herba Schizonepetae 2-4 part, Radix Saposhnikoviae 2-4 part.
4. the medicine of prevention respiratory infectious disease according to claim 3, its preferred weight part is: Folium Mori 3-4 part, Herba Menthae 2-3 part, Herba Schizonepetae 2-3 part, Radix Saposhnikoviae 2-3 part.
5. the medicine of prevention respiratory infectious disease according to claim 3, crude drug also has: Radix Adenophorae (Radix Glehniae) 2-4 part, Fructus Jujubae 2-4 part, Radix Glycyrrhizae 1-3 part.
6. the medicine thing of prevention respiratory infectious disease according to claim 5, its preferred weight part is: Radix Adenophorae (Radix Glehniae) 2-3 part, Fructus Jujubae 2-3 part, Radix Glycyrrhizae 1-2 part.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201010620278 CN102119967A (en) | 2010-12-21 | 2010-12-21 | Medicament for preventing respiratory infectious disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201010620278 CN102119967A (en) | 2010-12-21 | 2010-12-21 | Medicament for preventing respiratory infectious disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102119967A true CN102119967A (en) | 2011-07-13 |
Family
ID=44248695
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201010620278 Pending CN102119967A (en) | 2010-12-21 | 2010-12-21 | Medicament for preventing respiratory infectious disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102119967A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102579588A (en) * | 2012-03-28 | 2012-07-18 | 张继成 | Heat clearing and exterior syndrome relieving capsule |
| CN103638115A (en) * | 2013-12-05 | 2014-03-19 | 李德权 | Pure traditional Chinese medicine powder for preventing and treating bird flu |
| CN105232937A (en) * | 2015-11-03 | 2016-01-13 | 吕守礼 | Medicine for preventing respiratory infectious diseases in respiration medicine |
| CN108785559A (en) * | 2018-09-17 | 2018-11-13 | 河南科技大学第附属医院 | A kind of drug and preparation method thereof for treating respiratory tract infection |
| CN114767757A (en) * | 2022-04-14 | 2022-07-22 | 江西省科学院生物资源研究所 | Accurate fermentation method of compound Chinese herbal medicine by-product and application thereof |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101574407A (en) * | 2009-06-24 | 2009-11-11 | 贾高增 | Drug for preventing cold and preparation method thereof |
-
2010
- 2010-12-21 CN CN 201010620278 patent/CN102119967A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101574407A (en) * | 2009-06-24 | 2009-11-11 | 贾高增 | Drug for preventing cold and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 《中国中医急症》 19990131 焦树德 中医药防治流感 5 3-4 第8卷, 第1期 2 * |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102579588A (en) * | 2012-03-28 | 2012-07-18 | 张继成 | Heat clearing and exterior syndrome relieving capsule |
| CN102579588B (en) * | 2012-03-28 | 2014-01-15 | 张继成 | Heat clearing and exterior syndrome relieving capsule |
| CN103638115A (en) * | 2013-12-05 | 2014-03-19 | 李德权 | Pure traditional Chinese medicine powder for preventing and treating bird flu |
| CN105232937A (en) * | 2015-11-03 | 2016-01-13 | 吕守礼 | Medicine for preventing respiratory infectious diseases in respiration medicine |
| CN108785559A (en) * | 2018-09-17 | 2018-11-13 | 河南科技大学第附属医院 | A kind of drug and preparation method thereof for treating respiratory tract infection |
| CN108785559B (en) * | 2018-09-17 | 2021-07-02 | 河南科技大学第一附属医院 | Medicine for treating respiratory tract infection and preparation method thereof |
| CN114767757A (en) * | 2022-04-14 | 2022-07-22 | 江西省科学院生物资源研究所 | Accurate fermentation method of compound Chinese herbal medicine by-product and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102451356A (en) | Chinese medicinal herb cold tea | |
| CN111280526A (en) | Mask for preventing pneumonia caused by influenza virus and/or novel coronavirus and preparation method thereof | |
| CN102119967A (en) | Medicament for preventing respiratory infectious disease | |
| CN102000194B (en) | Traditional Chinese medicine composition for treating tympanitis and preparation method thereof | |
| CN104474104B (en) | A kind of Chinese medicine composition for preventing and treating infectious coryza of chicken and preparation method thereof | |
| CN102091250B (en) | Traditional Chinese medicine for treating acute tonsillitis | |
| CN103623267B (en) | Medication for treating allergic rhinitis | |
| CN103989788B (en) | Chinese medicine dropping for the treatment of rhinitis and preparation method thereof | |
| CN103720841B (en) | A kind of Chinese medicine preparation for the treatment of chronic suppurative otitis media and preparation method thereof | |
| CN103316086A (en) | Tibetan medicine for treating influenza and preparation method thereof | |
| Hoffmann | Easy breathing: natural treatments for asthma, colds, flu, coughs, allergies, and sinusitis | |
| CN103610915B (en) | Traditional Chinese medicine for treating swelling and pain in throat | |
| CN104940729A (en) | Traditional Chinese medicine for treating cholelithiasis | |
| CN103142733B (en) | Chinese medicine composition for treating upper respiratory infection | |
| CN109364220A (en) | It is a kind of for preventing, treating the Chinese medicine composition and method of the infection of the upper respiratory tract | |
| CN104800655A (en) | Traditional Chinese medicine for treating infantile pneumonia | |
| CN108210830A (en) | A kind of Chinese medicine composition and its application | |
| CN101095862A (en) | Chinese medicine preparation for treating diabetes respiratory tract infection | |
| CN107334916A (en) | A kind of medicine for treating rhinitis | |
| CN105920380A (en) | Repair traditional Chinese medicine used for treating blood cell infected by flaviviridae | |
| CN105770648A (en) | Oral traditional Chinese medicine preparation for treating cold | |
| CN104706998A (en) | Traditional Chinese medicine spray for treating allergic rhinitis in clinical care and preparation method thereof | |
| CN111700081A (en) | Chinese herbal medicine health incense for epidemic prevention and plague avoidance and processing method thereof | |
| CN104274750A (en) | Traditional Chinese medicinal composition for treating acute bronchitis and upper respiratory infection | |
| CN103638412B (en) | Multiple-effect Chinese medicinal formulae of a kind of quick elimination pulmonary persistent ailment and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20110713 |